Neurocrine Bioscience buy Citigroup Inc.
Start price
29.10.25
/
50%
€117.75
Target price
29.10.26
€174.28
Performance (%)
6.11%
Price
23.12.25
€124.95
Summary
This prediction is currently active. With a performance of 6.11%, the BUY prediction by Citigroup_Inc_ for Neurocrine Bioscience is trending in the right direction. This prediction currently runs until 29.10.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | 0.888% | 0.888% |
| iShares Core DAX® | 0.224% | 2.457% |
| iShares Nasdaq 100 | 0.371% | -0.320% |
| iShares Nikkei 225® | 0.972% | -0.829% |
| iShares S&P 500 | 0.417% | -0.157% |
Comments by Citigroup_Inc_ for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences (NASDAQ:NBIX) had its price target raised by analysts at Citigroup Inc. from $175.00 to $203.00. They now have a "buy" rating on the stock.
Ratings data for NBIX provided by MarketBeat